Comparative effect of Ocimum sanctum, Commiphora mukul, folic acid and ramipril on lipid peroxidation in experimentally-induced hyperlipidemia

Indian Journal of Experimental Biology

Volumn 48, Issue 3, 2010, Pages 299-305

  Khanna, Naresh ^a   Arora, Deepika ^a   Halder, Sumita ^a   Mehta, Ashish K ^a   Garg, Gobind R ^a   Sharma, Suman B ^a   Mahajan, Prabha ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant; Commiphora mukul; Folic acid; Hypercholesterolemic; Ocimum sanctum; Ramipril

Indexed keywords

CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLANT EXTRACT; RAMIPRIL; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VITAMIN B COMPLEX;

ANIMAL; ARTICLE; BASIL; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; CHOLESTEROL INTAKE; COMMIPHORA; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; PHYTOTHERAPY; RABBIT; TIME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CATALASE; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; COMMIPHORA; ERYTHROCYTES; FOLIC ACID; HYPERLIPIDEMIAS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MOLECULAR STRUCTURE; OCIMUM; PHYTOTHERAPY; PLANT EXTRACTS; RABBITS; RAMIPRIL; SUPEROXIDE DISMUTASE; TIME FACTORS; TRIGLYCERIDES; VITAMIN B COMPLEX;

COMMIPHORA; COMMIPHORA WIGHTII; OCIMUM; OCIMUM TENUIFLORUM; ORYCTOLAGUS CUNICULUS;

EID: 77954288441     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Goldstein J L, Hazzard W R, Schrott H G, Bierman E L & Motulsky A G, Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction,/Clin Invest, 52 (1973) 1533.
2. Harrison D, Kathy K G, Hornig B & Drexler H, Role of oxidative stress in atherosclerosis, Am J Cardiol, 91 (2003) 7A.
3. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results:ll. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251 (1984) 365.
4. Simons L A, Additive effect of plant sterol-ester margarine and corivastatin in lowering LDL cholesterol in primary hypercholesterolemia, Am J Cardiol, 90 (2002) 737.
5. Diaz M N, Frei B, Vita J A & Keney J F J, Antioxidants and atherosclerotic heart disease, New Eng J Med, 337 (1997) 408.
6. Uma Devi P, Radioprotective, anticarcinogenic and antioxidant properties of the Indian holy basil, Ocimum sanctum (Tulasi), Indian JExp Biol, 39 (2001) 185.
7. Uma Devi P & Ganasoundari, Modulation of glutathione and antioxidant enzymes by Ocimum sanctum and its role in protection against radiation injury, Indian J Exp Biol, 57(1999)262.
8. Khanna D S, Agarwal O P, Gupta S K & Arora R B, A biochemical approach to anti-atherosclerotic action of Commiphora mukul: An Indian indigenous drug in Indian 21 domestic pigs (Sus scrofa), Indian J Med Res, 57 (1969) 900.
9. Joardar M, Khanna N, Sharma K K & Dwivedi S, Effect of Terminalia arjuna, Commiphora mukul and Trigonella foenum-graecum in experimental hyperlipidemia and their role as adjuvant therapy in patients of coronary artery disease, MD Thesis infmitted to University of Delhi, Delhi, 1999.
10. Verma S K & Bordia A, Effect of Commiphora mukul (gum guggul) in patients of hyperlipidemia with special reference to HDL-cholesterol, Indian J Med Res, 87 (1988) 356.
11. Ulbricht C, Basch E, Szapary P, Hammerness P, Axentsev S, Boon H, Kroll D, Garraway L, Vora M & Woods J, Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration, Complement Ther Med, 13 (2005) 279.
12. Singh R B, Niaz M A & Ghosh S, Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia, Cardiovasc Drugs Ther, 8 (1994) 659.
13. Verhaar M C, Wever R M, Kastelein J J, Van Loon D, Milstien S, Koomans H A & Rabelink T J, Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial, Circulation, 100 (1999) 335.
14. Bellamy M F, McDowell I F, Ramsey M W, Brownlee M, Newcombe R G & Lewis M J, Oral folate enhances endothelial function in hyperhomocysteinaemic infjects, Eur J Clin Inves,29 (1999) 659.
15. Cano M J, Ayala A, Murillo M L & Carreras O. Protective effect of folic acid against oxidative stress produced in 21-day postpartum rats by maternal-ethanol chronic consumption during pregnancy and lactation period, Free Radic Res, 34 (2001)1.
16. Keidar S, Angiotensin, LDL peroxidation and atherosclerosis, Life Sci,63 (1998) 1.
17. Cavanagh E M, Fraga C G, Ferder L & Inserra F, Enalapril and captopril enhance antioxidant defenses in mouse tissues, AmJPhysiol, 272 (1997) 514.
18. Hayek T, Attias J, Smith J, Breslow J L & Keidar S, Atherosclerotic and antioxidant effects of captopril in apolipoprotein E-deficient mice, J Cardiovasc Pharmacol, 31(1998)540.
19. Nigris F, D'Armiento F P, Somma P, Casini A, Andreini I, Sarlo F, Mansueto G, De Rosa G, Bonaduce D, Condorelli M & Napoli C, Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma 35 LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice, Int J Cardiol, 81 (2001) 107.
20. Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H & Drexler H, Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase, Circulation, 103 (2001) 799.
21. Khanna N & Bhatia J, Antinociceptive action of Ocimum sanctum (Tulsi) in mice: possible mechanisms involved, J Ethnopharmacol, 88 (2003) 293.
22. Muthuraman A, Diwan V, Jaggi A S, Singh N & Singh D, Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats, J Ethnopharmacol, 120 (2008) 56.
23. Uma Devi P, Ganasoundari A, Rao B S & Srinivasan K K, In vivo radioprotection by Ocimum flavinoids: survival of mice, RadiatRes, 151 (1999)74.
24. Siddiqi H H, Effect of Khamira Abresham Hakim Arshad Wal on serum cholesterol levels in rabbits, Planta Medi, 12 (1964) 443.
25. Henry R J U M, Clinical chemistry, 2nd edition (Harper and Raw Publishers, New York) 1974, 1440.
26. McGowan M W, Artiss J D, Standberg D R & Zak B, A peroxidase-coupled method for the colorimetric determination of serum triglycerides, Clin Chem, 29 (1983) 538.
27. Fossati P & Prencipe L, Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide, Clin Chem, 28 (1982) 2077.
28. Satoh K, Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method, Clin Chem Ada, 90 (1978) 37.
29. Nandi A & Chatterjee I B, Assay of superoxide dismutase activity in animal tissues, J Biosci, 13 (1988) 305.
30. Sinha A K, Colorimetric assay of Catalase, Anal Biochem 47 (1972) 389.
31. Van Kampen E & Zijlstra W G, Standardization of hemoglobinometry. II. The hemiglobincyanide method, Clin Chim Acta, 6 (1961) 538.
32. MacMillan-Crow L A & Thompson J A, Tyrosine modifications and inactivations of active site Mn-SOD mutant (Y34F) by peroxynitrite, Arch Biochem Biophys 366 (1999) 82.
33. Cavalea V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, De Franceschi M, Belardinelli R & Guazzi M D, Oxidative stress and homocysteine in coronary artery disease, Clin Chem, 47 (2001) 887.
34. Verhaar M C, Wever RM, Kastelein J J, Van Dam T, Koomans H A & Rabelink T J, 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia, Circulation, 97 (1998) 237.
35. Durand P & Blache D, Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats, Atherosclerosis, 121 (1996)205.
36. Hayek T, Keidar S, Mei Y, Oiknin J & Breslow J, Effect of angiotensin converting enzyme inhibitors on LDL lipid peroxidation and atherosclerosis in apo-E-deficient mice, Circulation, 92 (1995) 2998.
37. Singh R B, Niaz M A & Ghosh S, Hypolipidemic and 42 antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia, Cardiovasc Drugs Ther, 8 (1994) 659.
38. Deng R, Therapeutic effects of guggul and its constituent 43 guggulsterone: Cardiovascular benefits, Cardiovasc Drug Rev, 25 (2007) 375.
39. Zhu N, Rafi M M, DiPaola R S, Xin J, Chin C K, Badmaev V, Ghai G, Rosen R T & Ho C T, Bioactive constituents 44 from gum guggul (Commiphora wightii), Phytochemistry, 56 (2001)723.
40. Godhwani S, Godhwani J L & Vyas D S, Ocimum sanctum: An experimental study evaluating its anti-inflammatory, analgesic and antipyretic activity in animals, J 45 Ethnopharmacol, 21 (1987) 153.
41. Sarkar A, Lavania S C, Pandey D N & Pant M C, Changes in the blood lipid profile after administration of Ocimum sanctum (Tulsi) leaves in the normal albino rabbits, Indian J Physiol Pharmacol, 38 (1994) 311.
42. Gupta S, Mediratta P K, Singh S, Sharma K K & Shukla R, Antidiabetic, antihypercholesterolemic and antioxidant effect of Ocimum sanctum (Linn) seed oil, Indian J Exp Biol, 44 (2006) 300.
43. Sharma M, Kishore K, Gupta S K, Joshi S & Arya D S, Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats, Mol Cell Biochem, 225 (2001)75.
44. Anandjiwala S, Kalola J& Rajani M, Quantification of eugenol, luteolin, ursolic acid, and oleanolic acid in black (Krishna Tulasi) and green (Sri Tulasi) varieties of Ocimum sanctum Linn. using high-performance thin-layer chromatography, J AOAC Int, 89 (2006) 1467.
45. Prakash P & Gupta N, Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review, Indian J Physiol Pharmacol, 49 (2005) 125.